Clinical Trial Update: Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy [Phase 1, Phase 2]

View source ↗

Summary

This update reports results from a Phase 1/2 study of NGM120 in combination therapy for patients with advanced solid tumors, including pancreatic cancer and met…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Castration-resistant Prostate Cancer
• Colorectal Cancer
• Esophageal Cancer
• Gastric Cancer
• Melanoma
• Non-small Cell Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• NGM120 (NGM120)

Snippet

Sponsor: NGM Biopharmaceuticals, Inc | Conditions: Pancreatic Cancer, Metastatic Castration-resistant Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-05-29